Hyaluronic Acid Gel, Intrauterine Device or Both for prevention of Intrauterine Adhesions after Hysteroscopic Myomectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202108487478996

Enrollment

Registered

2021-08-04

Start date

2021-08-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intrauterine adhesions after hysteroscopic myomectomy

Interventions

Group A

Group B

Group C

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1- patients diagnosed by vaginal ultrasounography to have single or multiple submucous fibroid type 0,1and type 2 if less than 4cm according to FIGO classification. 2-women aged aged 25-60 3- patients with no history of previous adhesions 4- a signed written consent 5- consent to have a second look hysteroscopy

Exclusion criteria

Exclusion criteria: 1-type 2 fibroid more than 4 cm 2-hypersensetivity to hyaluroinic acis gel or IUD 3-patients with fiboroid type 3 or more 4- genital tract malformation 5- genital infection

Design outcomes

Primary

Measure	Time frame
to assess the efficacy of 3 different techniques for prevention of intrauterine adhesions formation after hysteroscopic myomectomy	—

Secondary

Measure	Time frame
to assess endometrial thickness in all study groups after hysteroscopic myomectomy	—

Countries

Egypt

Contacts

Public Contactahmed salah

university

Dr_ahmedsalah5@yahoo.com01227944317

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026